Senores Pharmaceuticals Limited (NSE:SENORES)
719.60
+16.25 (2.31%)
At close: Sep 5, 2025
Senores Pharmaceuticals Company Description
Senores Pharmaceuticals Limited develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
The company offers critical care pharmaceutical solutions, such as analgesic/antipyretic, anesthetics and allied products, antibacterial/antibiotic, antiviral, antifungal, antioxidants, antineoplastic, blood line, cardiovascular, neurology, antacid, and vitamin and mineral preparation solutions; analgesic/anti-inflammatory/antipyretic, anti-diabetic, antimalarial, neutral supplements, and urinary tract generics; and management and consultancy services.
Senores Pharmaceuticals Limited was incorporated in 2017 and is based in Ahmedabad, India.
Senores Pharmaceuticals Limited
Country | India |
Founded | 2017 |
Industry | Drug Manufacturers - General |
Sector | Healthcare |
Employees | 194 |
CEO | Swapnil Shah |
Contact Details
Address: South Tower Ahmedabad, Gujarat 380054 India | |
Phone | 91 79 2999 9857 |
Website | senorespharma.com |
Stock Details
Ticker Symbol | SENORES |
Exchange | National Stock Exchange of India |
Fiscal Year | April - March |
Reporting Currency | INR |
ISIN Number | INE0RB801010 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Swapnil Jatinbhai Shah | MD and Director |
Deval Rajnikant Shah | Whole-Time Director and Chief Financial Officer |
Chetan Bipinchandra Shah | Whole-Time Director and Chief Operating Officer |
Hanuwant Singh Shaktawat | Assistant Vice President of Human Resources and Admin |
Vinay Kumar Mishra | Company Secretary and Compliance Officer |
Deepak Jain | Vice President of Regulatory Affairs |
Jignesh Shashikant Desai | President of Finance |